Raw Material Variability Control: Where Do We Go From Here?

By Cory Card, Principal Scientist, Cytiva

Managing raw material variation and process risks is critical to ensuring a high level of quality and consistency in drug development and manufacturing. Supply chain partners across the industry must work together to understand the issue of raw material variation and the impact it can have on the safety and efficacy of therapeutic products. A conjoined effort of all stakeholders is needed to identify best practices and apply them in their daily roles to mitigate potential risks.